NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is 67076P102. A total of 21 filers reported holding NYMOX PHARMACEUTICAL CORP in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $86,000 | +160.6% | 25,000 | 0.0% | 0.00% | +300.0% |
| Q2 2015 | $33,000 | +57.1% | 25,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $21,000 | +110.0% | 25,000 | 0.0% | 0.00% | – |
| Q4 2014 | $10,000 | -90.8% | 25,000 | 0.0% | 0.00% | -100.0% |
| Q3 2014 | $109,000 | -12.1% | 25,000 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $124,000 | -8.8% | 25,000 | 0.0% | 0.01% | -16.7% |
| Q1 2014 | $136,000 | -10.5% | 25,000 | 0.0% | 0.01% | -14.3% |
| Q4 2013 | $152,000 | -8.4% | 25,000 | 0.0% | 0.01% | -22.2% |
| Q3 2013 | $166,000 | +30.7% | 25,000 | 0.0% | 0.01% | +28.6% |
| Q2 2013 | $127,000 | – | 25,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEDBUSH SECURITIES INC | 200,701 | $873,000 | 0.14% |
| MARATHON CAPITAL MANAGEMENT | 30,000 | $131,000 | 0.12% |
| Advisors Asset Management, Inc. | 583,254 | $4,217,000 | 0.06% |
| Eidelman Virant Capital | 26,796 | $117,000 | 0.06% |
| WMS Partners, LLC | 69,250 | $301,000 | 0.05% |
| Brown Advisory Securities, LLC | 16,000 | $70,000 | 0.03% |
| CROFT-LEOMINSTER INC | 20,000 | $87,000 | 0.02% |
| WEBSTER BANK, N. A. | 19,657 | $86,000 | 0.02% |
| GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $109,000 | 0.01% |
| SCOTIA CAPITAL INC. | 18,195 | $79,000 | 0.00% |